Table 1. CD26 expression categorized by clinicopathological data of CRC patients.
Variable | No. of casesa | CD26 Expressiona | P * | ||
Low(n = 98) High(n = 45) | |||||
Age (years old): | >65 | 42 | 24 | 18 | 0.075 |
≤65 | 101 | 74 | 27 | ||
Gender: | Male | 81 | 56 | 25 | 0.858 |
Female | 62 | 42 | 20 | ||
Tumour size (cm3): | >5 | 51 | 35 | 16 | 1.000 |
≤5 | 92 | 63 | 29 | ||
Degree of Differentiation: | Well and moderate | 132 | 94 | 38 | 0.029 |
Poor | 7 | 2 | 5 | ||
TNM stage: | Stage I/II | 66 | 57 | 9 | <0.001 |
Stage III/IV | 76 | 40 | 36 | ||
Metastasis statusb: | No metastasis | 116 | 92 | 24 | <0.001 |
Metastasis | 27 | 6 | 21 | ||
Liver Metastasis: | No | 123 | 92 | 31 | <0.001 |
Yes | 20 | 6 | 14 |
TNM, tumour node metastasis.
The total number of cases may be less than 143 because of missing information.
Patients with distant metastasis were classified as “Metastasis”.
*χ2 test (or Fisher exact test in 2-sided)